AXIOS April 1, 2020
Dan Primack

Private equity is still working on opportunistic deals when it can get a break from portfolio triage, but it’s also boarding up the exits amid new questions about the speed of the coronavirus recovery.

The state of play: Sale processes are being shelved daily, even ones that already launched with investment bankers, data rooms, and interested suitors.

Within the past 24 hours:

  • KKR ended its efforts to sell Goodpack, a Singapore-based bulk container maker that was expected to fetch at least $2 billion, per Reuters.
  • EQT Partners suspended the auction for IFS, a Swedish ERP software company that had been expected to fetch more than €3 billion, per Bloomberg.
  • Bridgepoint stopped the sale process for Portuguese agrochemical company Rovensa,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Trends
Podcast: The State of Antitrust & Private Equity in Health Care w/ Brent Fulton
Metsera lands with $290m to take on obesity giants
Private equity bankruptcies in healthcare explode 112% in 5 years
California’s AB 3129: A New Hurdle for Private Equity Health Care Transactions on the Horizon?
In-home health screening startup Reperio raises $14M, inks deal with Uber

Share This Article